Annual report pursuant to Section 13 and 15(d)

Annual report pursuant to Section 13 and 15(d)

Acquisitions - Schedule of Unaudited Pro forma Information (Detail)

v3.19.3.a.u2
Acquisitions - Schedule of Unaudited Pro forma Information (Detail) - Genoptix - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Business Acquisition [Line Items]    
Revenue $ 367,988 $ 356,711
Net income (loss) attributable to common stockholders $ 1,401 $ (42,930)
Income (loss) per share (in dollars per share) $ 0.02 $ (0.53)
Basic (in shares) 85,618 80,426
Diluted (in shares) 91,568 80,426